Herbal Group of companies

  1. Pharmaceutical products are designed and developed in a way that takes account of the requirements of WHO- GMP and other associated codes such as those of good laboratory practice (GLP) and good clinical practice (GCP).

  2. Production and control operations are clearly specified in a written form and WHO-GMP standards are ensured

  3. All necessary controls on starting materials, intermediate and finished products and other in-process controls, calibrations, and validations are ensured.

  4. The finished product is correctly processed and checked according to the defined procedures.

  5. Pharmaceutical products are not sold or supplied before the authorized persons have certified that each production batch has been produced and controlled in accordance with the marketing requirements and any other regulations relevant to the production control and release of pharmaceutical products

  6. We are committed to the development, manufacture and supply of globally recognized solid dosage forms which are of the quality required for their intended use.

  7. Manufacturing and Quality Management Operations ensure that products meet customers and regulatory requirements and comply with their licensed specifications. The company complies with current local regulatory requirements and the requirements of the countries, where its products are exported.

  8. The continuous improvement of products and manufacturing activities is an essential element of this policy.